Literature DB >> 21992566

Off-clamp versus complete hilar control laparoscopic partial nephrectomy: comparison by clinical stage.

Soroush Rais-Bahrami1, Arvin K George, Amin S Herati, Arun K Srinivasan, Lee Richstone, Louis R Kavoussi.   

Abstract

UNLABELLED: Study Type--Therapy (case series). Level of Evidence 4. What's known on the subject? And what does the study add? Minimizing renal ischemia and reperfusion injury is an area of active investigation and is particularly significant in cases of laparoscopic renal surgery where the kidney experiences warm ischemia. Reports of partial clamping, early unclamping, and off-clamp laparoscopic partial nephrectomy have demonstrated potential technical modifications that can offer a protective role in preserving renal function. We investigated off-clamp laparoscopic partial nephrectomy for tumours with varying clinical stage to determine feasibility, perioperative outcomes, and renal functional changes when compared to a contemporary cohort of standard laparoscopic partial nephrectomy with complete hilar clamping performed by a single surgeon.
OBJECTIVE: • To compare the operative outcomes and oncological efficacy of off-clamp (OC) laparoscopic partial nephrectomy (LPN) vs complete hilar control (HC) LPN for stage T1a-T2 renal cell carcinoma.
METHODS: • Retrospective review of all LPNs between June 2006 and March 2010 was performed, stratifying 390 patients by clinical T stage (cT1a = 313, cT1b = 62, cT2 = 15). • Perioperative and postoperative parameters were analysed comparing patients who underwent OC LPN (n= 126) with those who had HC LPN (n= 264) collectively and within each clinical stage cohort.
RESULTS: • There was no significant difference in the proportion of OC LPN for cT1a tumours compared with cT1b and cT2, P= 0.21. • OC vs HC LPN patients had a greater estimated blood loss (EBL) but with no significant difference in perioperative blood transfusion rates. • When compared by clinical stage, EBL was greater only for clinical stage T1a disease (P= 0.02) but not cT1b (P= 0.91) or cT2 (P= 0.42) tumours. • There was no difference in the operative time or length of hospitalization between OC and HC LPN by stage: cT1a (P= 0.77 and P= 0.17), cT1b (P= 0.77 and P= 0.07) and cT2 (P= 0.42 and P= 0.66), respectively. • In our series, one case (0.3%) of HC LPN had a positive margin on final pathology, one case was converted to open partial nephrectomy (0.3%), and two cases of OC LPN (1.6%) were intraoperatively converted to HC LPN.
CONCLUSIONS: • OC LPN is a feasible surgical option for patients with cT1-T2 renal cell carcinoma that completely avoids renal ischaemic injury with the benefits of minimally invasive surgery. • LPN can be performed OC in patients with larger, more complex renal tumours without compromising the operative time, blood loss requiring transfusions, length of hospitalization, complication rates, or positive surgical margin rates compared with HC LPN.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21992566     DOI: 10.1111/j.1464-410X.2011.10592.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  22 in total

1.  Novel high-intensity focused ultrasound clamp--potential adjunct for laparoscopic partial nephrectomy.

Authors:  Jonathan D Harper; Anup Shah; Stuart B Mitchell; Yak-Nam Wang; Frank Starr; Michael R Bailey; Lawrence A Crum
Journal:  J Endourol       Date:  2012-09-10       Impact factor: 2.942

2.  Robotic surgery and hemostatic agents in partial nephrectomy: a high rate of success without vascular clamping.

Authors:  Luca Morelli; John Morelli; Matteo Palmeri; Cristiano D'Isidoro; Emanuele Federico Kauffmann; Dario Tartaglia; Giovanni Caprili; Roberta Pisano; Simone Guadagni; Gregorio Di Franco; Giulio Di Candio; Franco Mosca
Journal:  J Robot Surg       Date:  2015-06-30

3.  Utilization of a novel valveless trocar system during robotic-assisted laparoscopic prostatectomy.

Authors:  Arvin K George; Reinhard Wimhofer; Kate V Viola; Markus Pernegger; Walter Costamoling; Louis R Kavoussi; Wolfgang Loidl
Journal:  World J Urol       Date:  2015-03-01       Impact factor: 4.226

Review 4.  Zero-ischemia minimally invasive partial nephrectomy.

Authors:  Giuseppe Simone; Mariaconsiglia Ferriero; Rocco Papalia; Manuela Costantini; Salvatore Guaglianone; Michele Gallucci
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

Review 5.  Zero ischaemia partial nephrectomy: a call for standardized nomenclature and functional outcomes.

Authors:  Ahmad Alenezi; Giacomo Novara; Alexander Mottrie; Salah Al-Buheissi; Omer Karim
Journal:  Nat Rev Urol       Date:  2016-10-18       Impact factor: 14.432

6.  Perioperative and renal functional outcomes of laparoscopic partial nephrectomy (LPN) for renal tumours of high surgical complexity: a single-institute comparison between clampless and clamped procedures.

Authors:  Paolo Verze; Paolo Fedelini; Francesco Chiancone; Vito Cucchiara; Roberto La Rocca; Maurizio Fedelini; Clemente Meccariello; Alessandro Palmieri; Vincenzo Mirone
Journal:  World J Urol       Date:  2016-06-20       Impact factor: 4.226

Review 7.  [Standard surgery for small renal masses (<4 cm)].

Authors:  S K Frees; R Mager; H Borgmann; W Jäger; C Thomas; A Haferkamp
Journal:  Urologe A       Date:  2018-03       Impact factor: 0.639

8.  Initial experiences with the Hemopatch® as a hemostatic agent in zero-ischemia partial nephrectomy.

Authors:  F Imkamp; Y Tolkach; M Wolters; S Jutzi; M Kramer; T Herrmann
Journal:  World J Urol       Date:  2014-09-20       Impact factor: 4.226

9.  Factors Influencing the Operative Approach to Renal Tumors: Analyses According to RENAL Nephrometry Scores.

Authors:  Jeong Hyun Oh; Hyun Yul Rhew; Taek Sang Kim
Journal:  Korean J Urol       Date:  2014-02-14

10.  Selective clamping under the usage of near-infrared fluorescence imaging with indocyanine green in robot-assisted partial nephrectomy: a single-surgeon matched-pair study.

Authors:  Nina Harke; Georg Schoen; Frank Schiefelbein; Elmar Heinrich
Journal:  World J Urol       Date:  2013-11-06       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.